Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in LEGN — Legend Biotech Corp

CIK 1423053 MIAMI, FL
Back to LEGN Full portfolio

Position in LEGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,352,167
+$5,481,578 QoQ
Shares Held
516,980
+190.4% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LEGN Over Time

Shares Held

Position Value (USD)

Derivatives in LEGN

reported options exposure · as of Mar 31, 2026
CallValue
$1,179,468
CallShares
65,200
PutValue
$1,742,067
PutShares
96,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,537,601 across 374 Biotechnology names. LEGN ranks #96 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in LEGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,742,067 96,300
2026-03-31 $1,179,468 65,200
2026-03-31 $9,352,167 516,980
2025-12-31 $3,870,589 178,040
2025-12-31 $1,547,888 71,200
2025-12-31 $1,380,490 63,500
2025-09-30 $1,206,570 37,000
2025-09-30 $12,483,499 382,812
2025-09-30 $1,500,060 46,000
2025-06-30 $5,858,014 165,061
2025-06-30 $1,550,913 43,700
2025-06-30 $1,412,502 39,800
2025-03-31 $953,433 28,100
2025-03-31 $600,561 17,700
2025-03-31 $5,265,053 155,174
2024-12-31 $914,374 28,100
2024-12-31 $94,524,046 2,904,857
2024-12-31 $1,002,232 30,800
2024-09-30 $64,155,675 1,316,554
2024-09-30 $989,219 20,300
2024-09-30 $1,427,789 29,300
2024-06-30 $63,992,981 1,444,863
2024-06-30 $974,380 22,000
2024-06-30 $1,638,730 37,000
2024-03-31 $5,479,993 97,700
2024-03-31 $64,193,658 1,144,476
2024-03-31 $4,509,636 80,400
2023-12-31 $2,948,330 49,000
2023-12-31 $9,984,068 165,931
2023-12-31 $1,089,077 18,100
2023-09-30 $517,209 7,700
2023-09-30 $1,441,132 21,455
2023-09-30 $806,040 12,000
2023-06-30 $566,046 8,200
2023-06-30 $303,732 4,400
2023-06-30 $2,679,192 38,812
2023-03-31 $1,210,322 25,100
2023-03-31 $270,032 5,600
2023-03-31 $352,054 7,301
2022-12-31 $2,346,240 47,000
2022-12-31 $878,592 17,600
2022-12-31 $1,572,130 31,493
2022-09-30 $10,537,660 258,276
2022-09-30 $2,129,760 52,200
2022-09-30 $881,280 21,600
2022-06-30 $4,400,000 80,000
2022-06-30 $6,644,495 120,809
2022-06-30 $1,584,000 28,800
2022-03-31 $2,789,640 76,765
2022-03-31 $1,042,958 28,700

Report a Problem

Category
Description
Email (optional, for follow-up)